Acrospire Investment Management LLC bought a new stake in Lantheus Holdings Inc. (NASDAQ:LNTH) during the second quarter, Holdings Channel reports. The firm bought 29,135 shares of the company’s stock, valued at approximately $107,000. Acrospire Investment Management LLC owned 0.09% of Lantheus Holdings at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. BlackRock Institutional Trust Company N.A. raised its stake in Lantheus Holdings by 28.4% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 194,308 shares of the company’s stock valued at $367,000 after buying an additional 42,971 shares during the period. Spark Investment Management LLC raised its stake in Lantheus Holdings by 541.2% in the first quarter. Spark Investment Management LLC now owns 106,100 shares of the company’s stock valued at $200,000 after buying an additional 89,553 shares during the period. State Street Corp raised its stake in Lantheus Holdings by 10.3% in the first quarter. State Street Corp now owns 106,233 shares of the company’s stock valued at $200,000 after buying an additional 9,909 shares during the period. Gabelli Funds LLC raised its stake in Lantheus Holdings by 22.2% in the second quarter. Gabelli Funds LLC now owns 165,000 shares of the company’s stock valued at $606,000 after buying an additional 30,000 shares during the period. Finally, GSA Capital Partners LLP raised its stake in Lantheus Holdings by 3.7% in the second quarter. GSA Capital Partners LLP now owns 154,322 shares of the company’s stock valued at $566,000 after buying an additional 5,500 shares during the period. Institutional investors own 35.44% of the company’s stock.

Shares of Lantheus Holdings Inc. (NASDAQ:LNTH) traded down 0.24% during midday trading on Tuesday, hitting $8.43. 198,785 shares of the stock traded hands. The stock has a market capitalization of $256.16 million, a P/E ratio of 9.51 and a beta of 0.39. Lantheus Holdings Inc. has a 52 week low of $1.76 and a 52 week high of $10.10. The firm has a 50-day moving average price of $7.40 and a 200-day moving average price of $3.87.

Lantheus Holdings (NASDAQ:LNTH) last posted its earnings results on Thursday, August 4th. The company reported $0.24 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.06 by $0.18. Lantheus Holdings had a net margin of 9.00% and a negative return on equity of 11.75%. The firm had revenue of $78 million for the quarter, compared to analyst estimates of $72.66 million. On average, equities analysts predict that Lantheus Holdings Inc. will post $0.59 earnings per share for the current fiscal year.

LNTH has been the topic of several analyst reports. Zacks Investment Research upgraded shares of Lantheus Holdings from a “hold” rating to a “buy” rating and set a $4.75 target price on the stock in a report on Wednesday, June 29th. Credit Suisse Group AG set a $4.00 price objective on shares of Lantheus Holdings and gave the stock a “hold” rating in a research report on Friday, August 5th. Finally, Jefferies Group reissued a “buy” rating on shares of Lantheus Holdings in a research report on Friday, August 5th. Three research analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $6.60.

Lantheus Holdings Company Profile

Lantheus Holdings, Inc develops, manufactures and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The Company’s portfolio of approximately 10 commercial products is spread across a range of imaging modalities.

5 Day Chart for NASDAQ:LNTH

Want to see what other hedge funds are holding LNTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lantheus Holdings Inc. (NASDAQ:LNTH).

Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.